About
NK Cell Therapy
Areas of Focus
Categories
Stem Cell & Cellular Therapy
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
73
By Phase
PHASE1/PHASE2: 1PHASE1: 1NA: 1PHASE2: 1
By Status
COMPLETED: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05588453Lead Sponsor
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
PHASE1/PHASE2Recruiting
30 participants
Started: Mar 1, 2023 · Completed: Nov 15, 2025
NCT02120222Lead Sponsor
Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery
PHASE1Completed
8 participants
Started: Aug 22, 2014 · Completed: Apr 8, 2018
NCT01087775Lead Sponsor
GAME Veterans With PTSD Using Computer-Based Cognitive Training
NACompleted
25 participants
Started: Apr 30, 2010 · Completed: Sep 30, 2014
NCT00201760Lead Sponsor
Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer
PHASE2Completed
10 participants
Started: Feb 25, 2005 · Completed: Oct 31, 2009
Locations (1)
Headquarters
Oxford, UK
Map
Loading map...